Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Sibutramine Cardiovascular Morbidity/Mortality Outcomes Study in Overweight or Obese Subjects at Risk of a Cardiovascular Event

NCT00234832 is registered in ClinicalTrials.gov with Abbott as lead sponsor.

NCT NCT00234832
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00234832 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Sibutramine Cardiovascular Morbidity/Mortality Outcomes Study in Overweight or Obese Subjects at Risk of a Cardiovascular Event
Lead sponsor
Abbott
Phase
Phase 3
Overall status
Completed
Start date
January 31, 2003
Completion date
November 30, 2009
Enrollment
10,777 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

obesity